Cholesterol lowering drugs linked to improved gut bacteria composition in obese people

Obese Europeans who are treated with cholesterol lowering drugs have not only lower values of blood LDL cholesterol and markers of inflammation but in addition a more healthy gut bacteria profile than those obese who are not prescribed statins. This is reported in a new study in Nature by the EU-funded MetaCardis consortium.